1-(TERT-BUTOXYCARBONYL)-4-(4-CHLOROPHENYL)PIPERIDINE-4-CARBOXYLIC ACID, 95.0%, 1g

3-{[3-Chloro-5-(trifluoromethyl)-2-pyridinyl]oxy}aniline, 95.0%, 5g

2',3'-dimethyl-3-(2,6-dimethylphenyl)propiophenone, 97.0%, 1g

tert-Butyl N-(3R)-1-[6-(trifluoromethyl)pyrimidin-4-yl]pyrrolidin-3-ylcarbamate, 1g

2,4,5-Trifluoro-3-hydroxybenzoic Acid>98.0%(GC)(T)25g

Fluorescein di-O-acetate (FDA), >98.0%(HPLC), 100g

4'-Ethoxybenzylidene-4-butylaniline>99.0%(T)(GC)500g

Vigreux column with glass shell, 300 mm, 1 Piece

N-(3,4-Dihydro-5-methoxy-2-naphthalenyl)propanamide, 97%, 250mg

methyl 5-formylpyridine-3-carboxylate, 95.0%, 250mg

Methyl 3-bromo-2-pyridinecarboxylate, 97.0%, 100g

1-(Pyridazin-4-yl)ethanamine hydrochloride, 95.0%, 1g

2-Azetidinone, 1-(4-fluorophenyl)-3-[(3S)-3-(4-fluorophenyl)-3-hydroxypropyl]-4-(4-hydroxyphenyl)-, (3R,4S)-, 95%+, 250mg